Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Darrah PA, Bolton DL, Lackner AA, Kaushal D, Aye PP, Mehra S, Blanchard JL, Didier PJ, Roy CJ, Rao SS, Hokey DA, Scanga CA, Sizemore DR, Sadoff JC, Roederer M, Seder RA.

J Immunol. 2014 Aug 15;193(4):1799-811. doi: 10.4049/jimmunol.1400676. Epub 2014 Jul 14.

2.

Experimental aerosolized guinea pig-adapted Zaire ebolavirus (variant: Mayinga) causes lethal pneumonia in guinea pigs.

Twenhafel NA, Shaia CI, Bunton TE, Shamblin JD, Wollen SE, Pitt LM, Sizemore DR, Ogg MM, Johnston SC.

Vet Pathol. 2015 Jan;52(1):21-5. doi: 10.1177/0300985814535612. Epub 2014 May 14.

PMID:
24829285
3.

Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Rahman S, Magalhaes I, Rahman J, Ahmed RK, Sizemore DR, Scanga CA, Weichold F, Verreck F, Kondova I, Sadoff J, Thorstensson R, Spångberg M, Svensson M, Andersson J, Maeurer M, Brighenti S.

Mol Med. 2012 May 9;18:647-58. doi: 10.2119/molmed.2011.00222.

4.

Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.

Sizemore DR, Warner EA, Lawrence JA, Thomas LJ, Roland KL, Killeen KP.

Hum Vaccin Immunother. 2012 Mar;8(3):371-83. doi: 10.4161/hv.18670. Epub 2012 Feb 13.

PMID:
22327496
5.

High content cellular immune profiling reveals differences between rhesus monkeys and men.

Magalhaes I, Vudattu NK, Ahmed RK, Kühlmann-Berenzon S, Ngo Y, Sizemore DR, Wehlin L, Weichold F, Andersson J, Skeiky YA, Sadoff J, Gaines H, Thorstensson R, Spångberg M, Maeurer MJ.

Immunology. 2010 Sep;131(1):128-40. doi: 10.1111/j.1365-2567.2010.03284.x. Epub 2010 May 10.

6.

rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector.

Magalhaes I, Sizemore DR, Ahmed RK, Mueller S, Wehlin L, Scanga C, Weichold F, Schirru G, Pau MG, Goudsmit J, Kühlmann-Berenzon S, Spångberg M, Andersson J, Gaines H, Thorstensson R, Skeiky YA, Sadoff J, Maeurer M.

PLoS One. 2008;3(11):e3790. doi: 10.1371/journal.pone.0003790. Epub 2008 Nov 21.

7.

Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.

Sizemore DR, Warner B, Lawrence J, Jones A, Killeen KP.

Vaccine. 2006 May 1;24(18):3793-803. Epub 2005 Jul 26.

PMID:
16135393
8.

Enterotoxigenic Escherichia coli virulence factors and vaccine approaches.

Sizemore DR, Roland KL, Ryan US.

Expert Rev Vaccines. 2004 Oct;3(5):585-95. Review.

PMID:
15485338
9.

Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization.

Sizemore DR, Branstrom AA, Sadoff JC.

Vaccine. 1997 Jun;15(8):804-7.

PMID:
9234519
10.

Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages.

Sizemore DR, Elsinghorst EA, Eck LC, Branstrom AA, Hoover DL, Warren RL, Rubin FA.

Infect Immun. 1997 Jan;65(1):309-12.

11.

Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.

Sizemore DR, Branstrom AA, Sadoff JC.

Science. 1995 Oct 13;270(5234):299-302.

PMID:
7569980
12.

Tn5 mutagenesis of the Salmonella typhimurium 100 kb plasmid: definition of new virulence regions.

Sizemore DR, Fink PS, Ou JT, Baron L, Kopecko DJ, Warren RL.

Microb Pathog. 1991 Jun;10(6):493-9.

PMID:
1665537
13.

Method for identifying microbial antigens that stimulate specific lymphocyte responses: application to Salmonella.

Warren RL, Lu D, Sizemore DR, Baron LS, Kopecko DJ.

Proc Natl Acad Sci U S A. 1990 Dec;87(24):9823-7.

Supplemental Content

Loading ...
Support Center